Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:1022-1029
Published online before print April 7, 2005, doi: 10.1161/01.RES.0000165480.82737.33
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/9/1022    most recent
01.RES.0000165480.82737.33v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barth, A. S.
Right arrow Articles by Nabauer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barth, A. S.
Right arrow Articles by Nabauer, M.
Right arrowPubmed/NCBI databases
*GEO DataSet*GEO Profiles
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Functional genomics
Right arrow Gene expression
Right arrow Ion channels/membrane transport
Right arrowRelated Article
(Circulation Research. 2005;96:1022.)
© 2005 American Heart Association, Inc.


Clinical Research

Reprogramming of the Human Atrial Transcriptome in Permanent Atrial Fibrillation

Expression of a Ventricular-Like Genomic Signature

Andreas S. Barth, Sylvia Merk, Elisabeth Arnoldi, Ludwig Zwermann, Patrick Kloos, Mathias Gebauer, Klaus Steinmeyer, Markus Bleich, Stefan Kääb, Martin Hinterseer, Heike Kartmann, Eckart Kreuzer, Martin Dugas, Gerhard Steinbeck, Michael Nabauer

From the Departments of Medicine I (A.S.B., E.A., L.Z., P.K., S.K., M.H., H.K., G.S., M.N.) and Cardiac Surgery (E.K.), University Hospital Grosshadern, and the Department of Medical Informatics, Biometrics, and Epidemiology (S.M., M.D.), Ludwig-Maximilians-University, Munich, Germany; Aventis Pharma Deutschland GmbH (M.G., K.S., M.B.), Frankfurt am Main, Germany; and the Institute of Physiology (M.B.), Christian- Albrechts-University, Kiel, Germany.

Correspondence to Dr med Andreas S. Barth, Department of Medicine I, University Hospital Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany. E-mail andreas.barth{at}med.uni-muenchen.de

Atrial fibrillation is associated with increased expression of ventricular myosin isoforms in atrial myocardium, regarded as part of a dedifferentiation process. Whether reexpression of ventricular isoforms in atrial fibrillation is restricted to transcripts encoding for contractile proteins is unknown. Therefore, this study compares atrial mRNA expression in patients with permanent atrial fibrillation to atrial mRNA expression in patients with sinus rhythm and to ventricular gene expression using Affymetrix U133 arrays. In atrial myocardium, we identified 1434 genes deregulated in atrial fibrillation, the majority of which, including key elements of calcium-dependent signaling pathways, displayed downregulation. Functional classification based on Gene Ontology provided the specific gene sets of the interdependent processes of structural, contractile, and electrophysiological remodeling. In addition, we demonstrate for the first time a prominent upregulation of transcripts involved in metabolic activities, suggesting an adaptive response to increased metabolic demand in fibrillating atrial myocardium. Ventricular-predominant genes were 5 times more likely to be upregulated in atrial fibrillation (174 genes upregulated, 35 genes downregulated), whereas atrial-specific transcripts were predominantly downregulated (56 genes upregulated, 564 genes downregulated). Overall, in fibrillating atrial myocardium, functional classes of genes characteristic of ventricular myocardium were found to be upregulated (eg, metabolic processes), whereas functional classes predominantly expressed in atrial myocardium were downregulated (eg, signal transduction and cell communication). Therefore, dedifferentiation with adoption of a ventricular-like signature is a general feature of the fibrillating atrium.


Key Words: atrial fibrillation • gene expression • atrial myocardium • functional genomics


Related Article:

Ventricularization of Atrial Gene Expression in the Fibrillating Heart?
Gordon F. Tomaselli
Circ. Res. 2005 96: 923-924. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. Burstein and S. Nattel
Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 802 - 809.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mayr, S. Yusuf, G. Weir, Y.-L. Chung, U. Mayr, X. Yin, C. Ladroue, B. Madhu, N. Roberts, A. De Souza, et al.
Combined metabolomic and proteomic analysis of human atrial fibrillation.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
O. Adam, G. Frost, F. Custodis, M. A. Sussman, H.-J. Schafers, M. Bohm, and U. Laufs
Role of Rac1 GTPase Activation in Atrial Fibrillation
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 359 - 367.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Cardin, E. Libby, P. Pelletier, S. Le Bouter, A. Shiroshita-Takeshita, N. Le Meur, J. Leger, S. Demolombe, A. Ponton, L. Glass, et al.
Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation
Circ. Res., February 16, 2007; 100(3): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Barth, R. Kuner, A. Buness, M. Ruschhaupt, S. Merk, L. Zwermann, S. Kaab, E. Kreuzer, G. Steinbeck, U. Mansmann, et al.
Identification of a Common Gene Expression Signature in Dilated Cardiomyopathy Across Independent Microarray Studies
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1610 - 1617.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. El-Armouche, P. Boknik, T. Eschenhagen, L. Carrier, M. Knaut, U. Ravens, and D. Dobrev
Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation
Circulation, August 15, 2006; 114(7): 670 - 680.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. V. Podgoreanu and J. P. Mathew
Prophylaxis Against Postoperative Atrial Fibrillation: Current Progress and Future Directions
JAMA, December 28, 2005; 294(24): 3140 - 3142.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. V. Podgoreanu and D. A. Schwinn
New Paradigms in Cardiovascular Medicine: Emerging Technologies and Practices: Perioperative Genomics
J. Am. Coll. Cardiol., December 6, 2005; 46(11): 1965 - 1977.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. F. Tomaselli
Ventricularization of Atrial Gene Expression in the Fibrillating Heart?
Circ. Res., May 13, 2005; 96(9): 923 - 924.
[Full Text] [PDF]